Pre‑Market Shockers: **Dick's Sporting Goods**, **AMD**, **Kura Oncology** and Others

During pre‑market hours, Dick's Sporting Goods, Advanced Micro Devices (AMD) and Kura Oncology captured investors' attention.

Retail Giant Dick's Surges

■Up %3.2 to $78.15 per share.

■New promotional campaigns and e‑commerce integration are fueling optimism.

■Analysts have lifted the year‑end target to $85.

Chip Powerhouse AMD Keeps the Momentum

■Rises %1.8 to close at $112.40.

■Positive outlook from the latest data‑center GPU launch and ongoing chip shortages.

■$130 price objective remains unchanged, according to Morgan Stanley.

Biotech Setback: Kura Oncology Slides

■Falls %5.4 to $4.60.

■Clinical trial timelines are lagging behind expectations.

■Goldman Sachs has revised the target down to $6.00.

Market Breadth and Sector Clash

■The S&P 500 is up %0.6 in pre‑market trading, led by tech and retail stocks.

■The Nasdaq gains %0.9, while the Dow Jones adds %0.4.

■Investor risk appetite is buoyed by the Federal Reserve's pause on rate hikes.

Gökberk Uçar: The pre‑market moves highlight the impact of short‑term liquidity flows and institutional buying in high‑liquidity equities like Dick's and AMD. Kura Oncology's decline signals lingering uncertainty in the biotech space. Overall, a softer interest‑rate outlook and improving consumer spending expectations should continue to support risk‑on assets.